iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests C.N., Y.N-K., and T.O. are co-inventors of intellectual property licensed to Kaneka Corp."
"We are grateful to Makoto Ikeya (Kyoto University) for cell induction, Atsushi Sakai (Nippon Medical School) for brain sectioning, Masumi Shimizu (Nippon Medical School) for FACS and cell sorting, Yurika Sawa (TechnoPro, Inc., TechnoPro R&D Co.) for histopathological studies, and Kaneka Corp. for BMMSC donation. We would also like to thank the staff of the Laboratory for Clinical Research, Collaborative Research Center for supporting this work. This research was supported by 10.13039/100009619AMED under grant JP22ae0201005 and 10.13039/501100001691JSPS KAKENHI grants JP20H03788 and JP18K08981."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025